| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/04/2006 | US7070786 RSV proteins, antibodies, compositions, methods and uses |
| 07/04/2006 | US7070785 Heat shock proteins for use in enhancing cellular factor production |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070782 Prostate-specific membrane antigen |
| 07/04/2006 | US7070781 Nontoxic mucosal adjuvant |
| 07/04/2006 | US7070780 Treatment of demyelinating autoimmune disease with ordered peptides |
| 07/04/2006 | US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 07/04/2006 | US7070778 treating breast concer by administering a monoclonal antibody with an oligo- beta -(1,3)-glucan and a carrier |
| 07/04/2006 | US7070777 Method for inhibiting inflammation with an antibody that binds the 5C8 protein |
| 07/04/2006 | US7070776 inhibiting an immune response by reacting B7 positive cells with an antibody which binds with B7 antigen having a specific amino acid sequence |
| 07/04/2006 | US7070775 Recombinant A2-specific TNFα specific antibodies |
| 07/04/2006 | US7070774 Antibodies that bind testis-specific insulin homolog polypeptides |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 06/29/2006 | WO2006069262A2 Compositions of influenza viral proteins and methods of use thereof |
| 06/29/2006 | WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 06/29/2006 | WO2006069198A1 Flagellin related polypeptides and uses thereof |
| 06/29/2006 | WO2006069081A2 USE OF ANTI-Aβ ANTIBODY TO TREAT TRAUMATIC BRAIN INJURY |
| 06/29/2006 | WO2006069073A2 Use of angiopoietins in anti-tumor therapy |
| 06/29/2006 | WO2006068975A2 Binding proteins specific for human matriptase |
| 06/29/2006 | WO2006068867A1 Combination therapy for b cell disorders |
| 06/29/2006 | WO2006068822A1 Notch receptor agonists and uses |
| 06/29/2006 | WO2006068794A2 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof |
| 06/29/2006 | WO2006068625A1 Novel snake toxin |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068307A1 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 06/29/2006 | WO2006068077A1 Novel vaccine for fish diseases against strepcococcemia |
| 06/29/2006 | WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 06/29/2006 | WO2006067632A2 Saccharide conjugate vaccines |
| 06/29/2006 | WO2006067518A2 Vaccines against neisseria meningitidis |
| 06/29/2006 | WO2006067469A2 Compositions comprising opa protein epitopes |
| 06/29/2006 | WO2006067211A1 Rescue of influenza virus |
| 06/29/2006 | WO2006067134A1 Combination treatment for multiple sclerosis |
| 06/29/2006 | WO2006066878A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | WO2006066599A2 Mas related g protein coupled receptors as drug targets |
| 06/29/2006 | WO2006066408A1 Cancer specific antibody and cell surface proteins |
| 06/29/2006 | WO2006041641A3 Therapeutic agents with decreased toxicity |
| 06/29/2006 | WO2006037421A3 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 06/29/2006 | WO2006027468A3 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 06/29/2006 | WO2006025990A3 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 06/29/2006 | WO2006023420A3 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 06/29/2006 | WO2006021893A3 Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, fn staphylococcus aureus |
| 06/29/2006 | WO2006020915A3 Detecting fungi in human samples |
| 06/29/2006 | WO2006020319A3 Methods and compositions for producing target cell reactive lymphocytes in a subject |
| 06/29/2006 | WO2006015079A3 Erm family binding agents and their use in diagnosis and treatment of proliferative conditions |
| 06/29/2006 | WO2006002377A3 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 06/29/2006 | WO2005120437A3 Method for treating lupus |
| 06/29/2006 | WO2005115480A3 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005087793A3 Immunostimulatory compositions and uses thereof |
| 06/29/2006 | WO2005084410A3 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 06/29/2006 | WO2005080417A3 Recombinant viruses with heterologous envelope proteins |
| 06/29/2006 | WO2005042581A8 Modified anti-cd52 antibody |
| 06/29/2006 | WO2005019435A3 Anti-cancer vaccines |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | WO2004019880A3 Aw755252-interacting proteins and use thereof |
| 06/29/2006 | WO2004002412A3 A method and composition to elicit an effective autologous antitumoral immune response in a patient |
| 06/29/2006 | WO2003106644A3 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 06/29/2006 | US20060143732 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 06/29/2006 | US20060143723 Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 06/29/2006 | US20060142546 Immunogenic muc1 glycopeptides |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142221 Vaccine |
| 06/29/2006 | US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2006 | US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 06/29/2006 | US20060142187 Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activity |
| 06/29/2006 | US20060141602 Packaging of positive-strand RNA virus replicon particles |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141563 Mutant protein and refolding method |
| 06/29/2006 | US20060141548 Immunoassays for everolimus |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060141482 Method and multicomponent conjugates for treating cancer |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141453 Prokineticin polypeptides, related compositions and methods |
| 06/29/2006 | US20060141444 Adherent entities and uses therefor |
| 06/29/2006 | US20060141040 Injectable non-aqueous suspension |
| 06/29/2006 | US20060140990 Composition for topical treatment of mixed vaginal infections |
| 06/29/2006 | US20060140983 Dendritic cells loaded with heat shocked melanoma cell bodies |
| 06/29/2006 | US20060140982 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 06/29/2006 | US20060140981 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 06/29/2006 | US20060140980 Immunization of non-human mammals against streptococcus equi |
| 06/29/2006 | US20060140979 Antigenic polypeptides |
| 06/29/2006 | US20060140978 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy |
| 06/29/2006 | US20060140977 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 06/29/2006 | US20060140976 Trivalent vaccine with material antibody transfer via the milk |
| 06/29/2006 | US20060140975 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 06/29/2006 | US20060140972 Staphylococcus saprophyticus nucleic acids and polypeptides |
| 06/29/2006 | US20060140971 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| 06/29/2006 | US20060140970 Proteic binding partners of TCTP and methods of modulating tumor reversion or cell apoptosis |
| 06/29/2006 | US20060140969 Hypoallergenic polypeptides based on fish parvalbumin |
| 06/29/2006 | US20060140968 Tumor antigen peptide that is a fragment of a protein and binds to an HLA-A24 antigen and is recognized by cytotoxic T lymphocytes; use in medicaments, prophylactics or diagnostics for tumors that utilize in vivo or in vitro such tumor antigen protein, genes, tumor antigen peptides, or derivatives |
| 06/29/2006 | US20060140967 Immunotherapy; detecting CD8 expressing T cells; biodrugs generate an immune response to breast cancer and prostate cancer cells that express TARP (T cell receptor gamma Alternate Reading Frame Protein); vaccines |
| 06/29/2006 | US20060140966 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 06/29/2006 | US20060140965 Immunogenic compositions comprising a xenogenic prostate protein p501s |
| 06/29/2006 | US20060140964 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 06/29/2006 | US20060140963 Cytotoxicity mediation of cells evidencing surface expression of CD59 |